Journal of Hepatology
Volume 53, Issue 2 , Pages 228-229 , August 2010

MARS: The ultimate warrior against pruritus of cholestasis?

  • O. Chazouillères

      Affiliations

    • Corresponding Author InformationAddress: Service d’Hépatologie, Hôpital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75571 Paris Cedex 12, France. Tel.: +33 149282379; fax: +33 149282107.

References 

  1. Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther. 2003;17:857–870
  2. Bergasa NV. The pruritus of cholestasis. J Hepatol. 2005;43:1078–1088
  3. Kremer AE, Martens JJ, Kulik W, Williamson C, Moolenaar WH, Kondrackiene J, et al. Increased serum autotaxin activity in cholestatic pruritus. Hepatology. 2009;50:376A;[Abstract]
  4. Schmelz M. Itch and pain. Dermatol Ther. 2005;18:304–307
  5. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237–267.
  6. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50:291–308
  7. Stapelbroek JM, van Erpecum KJ, Klomp LW, Venneman NG, Schwartz TP, van Berge Henegouwen GP, et al. Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis. Hepatology. 2006;43:51–53
  8. Neuberger J, Gimson A, Davies M, Akyol M, O’Grady J, Burroughs A, et al. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut. 2008;57:252–257
  9. Pares A, Herrera M, Aviles J, Sanz M, Mas A. Treatment of resistant pruritus of cholestasis with albumin dialysis. Combined analysis of patients from three centers. J Hepatol. 2010;53:307–312
  10. Carpentier B, Gautier A, Legallais C. Artificial and bioartificial liver devices: present and future. Gut. 2009;58:1690–1702
  11. Leckie P, Tritto G, Proven A, Cheshire L, Mookerjee RP, Jones DE, et al. “Out-patient” albumin dialysis for intractable itch in chronic cholestatic liver disease patients is a feasible, safe and efficacious alternative to liver transplantation. Hepatology. 2009;50:376A;[Abstract]
  12. Silveira MG, Brunt EM, Heathcote J, Gores GJ, Lindor KD, Mayo MJ. AASLD endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis. Hepatology. 2010;
  13. Kremer AE, Martens JJ, Kulik W, Williamson C, Moolenaar WH, Kondrackiene J, et al. J Hepatol. 2010;52:S1;[Abstract]
  14. Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163–2182

PII: S0168-8278(10)00413-7

doi: 10.1016/j.jhep.2010.04.007

Journal of Hepatology
Volume 53, Issue 2 , Pages 228-229 , August 2010

Article Tools